Delivery Order SPE2DB20D3104-SPE2DB22FV7S3

Award Date 6/24/22
Potential Completion Date 6/27/22
Potential Value $3.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4564416235 - Nitroglycerin 400 MCG Spray 12GM to the Defense Logistics Agency (DLA). The $1,814.05 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for the company to deliver a...
This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FK1K5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,834.65 Firm Fixed Price delivery order is for the supply of 4557563969 - Nitroglycerin 400 MCG Spray, 12GM. This award was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,581.92 firm-fixed-price delivery order is for the supply of 4,556,078,130 units of Nitroglycerin 400 MCG Spray 12GM. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. (doing business as Amerisourcebergen) with the DLA Troop Support Medical, which serves as the...
This federal contract award, SPE2DB22D3016|SPE2DB24FAMV3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,791.56 delivery order is for Nitroglycerin 400 MCG Spray 12GM and has a completion date of February 22, 2024. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,318.37 Firm Fixed Price delivery order supports the supply of 4554905111 - Nitroglycerin 400 MCG Spray 12GM to the DLA. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, valued at $1,121.45, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of nitroglycerin 400 MCG spray, a critical pharmaceutical product, to support military healthcare programs. The award is issued as a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.80 Firm Fixed Price Delivery Order is for the supply of 4,556,078,065 units of Nitroglycerin 400 MCG Spray 4.9GM. The contract has an ultimate completion date of January 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,033,241 units of Nitroglycerin 400 MCG Spray 12GM, a pharmaceutical product, with a ceiling value of $1,371.99. The contract has an ultimate completion date of December 8, 2023 and was awarded on December 7, 2023. This delivery order is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of nitroglycerin 400 mcg spray, 12 gm, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,936.44, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. This award is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of nitroglycerin 400 mcg spray (4.9 gm) to the Defense Logistics Agency (DLA). The $1,825.44 Firm Fixed Price contract has a completion date of January 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the efficient procurement of a wide range of pharmaceutical...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB22FV7S3
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3104|SPE2DB22FV7S3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,450.44 Firm Fixed Price delivery order is for the procurement of 4557635572 - Nitroglycerin 400 MCG Spray 4.9GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:37 AM